Assyro AI

Orange Book product · Generic (ANDA)

EPROSARTAN MESYLATE

EPROSARTAN MESYLATE

Generic (ANDA)ANDA 202012DISCN PHARMOBEDIENT

At a glance

Nov 16, 2011

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Nov 16, 2011

    14 yr 10 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

EPROSARTAN MESYLATE

Strength

EQ 400MG BASE

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

ANDA 202012

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of EPROSARTAN MESYLATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.